Dec 19 2024 3 mins 3
The company is also planning to conduct the clinical trial at sites in the EU.
ViGeneron Receives FDA Authorization to Launch Clinical Trial for mRNA Trans-splicing Gene Therapy for Stargardt Disease
1.0x
00:00
00:00
